Market Overview

Sorrento Therapeutics, Inc. (Nasdaq: SRNE)

13.13 +0.72 (5.80%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/31/20HC Wainwright & Co.MaintainsBuy30.0
5/26/20Dawson JamesInitiates Coverage OnBuy24.0
3/30/20H.C. WainwrightReiteratesBuy24.0
10/07/19JMP SecuritiesInitiates Coverage OnMarket Outperform21.0
3/20/19B. Riley FBRMaintainsBuy12.0
6/28/18B. Riley FBRInitiates Coverage OnBuy14.3
4/03/18H.C. WainwrightMaintainsBuy40.0
11/15/17OppenheimerMaintainsOutperform6.0
8/04/17OppenheimerInitiates Coverage OnOutperform7.0
10/03/16Roth CapitalInitiates Coverage onBuy

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter